General https://www.benzinga.com/views/taxonomy/term/18467 en Pfizer Plans To Test Coronavirus Vaccine On Thousands Of Patients By September https://www.benzinga.com/general/biotech/20/05/16018248/pfizer-plans-to-test-coronavirus-vaccine-on-thousands-of-patients-by-september <p><strong>Pfizer Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>) is planning to significantly expand clinical trials of its novel coronavirus (COVID-19) vaccine candidate by September, the company&#39;s chief executive officer Albert Bourla told CNBC on Tuesday.</p> <h3>Pfizer Aims For October Approval</h3> <p>The pharmaceutical company is currently testing four different variations of its BNT 162 COVID-19 vaccine, as part of the phase one trials, Bourla said at the CNBC &quot;Healthy Returns Virtual Summit.&quot;</p> <p>Pfizer is expecting to test up to 360 people in the trial, and if one or two vaccine versions signal progress, it will launch a wider study involving thousands of volunteers by September, according to Bourla.</p> <p>The CEO ...</p><p><a href=https://www.benzinga.com/general/biotech/20/05/16018248/pfizer-plans-to-test-coronavirus-vaccine-on-thousands-of-patients-by-september alt=Pfizer Plans To Test Coronavirus Vaccine On Thousands Of Patients By September>Full story available on Benzinga.com</a></p> Biotech BNTX CNBC Coronavirus Covid-19 Government INO MRNA News PFE vaccine Health Care FDA Media General INO US45773H1023 PFE US7170811035 MRNA US56804Q1022 BNTX News Biotech Government Health Care FDA Media General Benzinga Wed, 13 May 2020 06:18:34 +0000 Neer Varshney 16018248 at https://www.benzinga.com 'Hamilton' Movie To Stream On Disney+ In July https://www.benzinga.com/news/20/05/16018174/hamilton-movie-to-stream-on-disney-in-july <p>The hit musical &quot;Hamilton&quot; will become available on the <strong>Walt Disney Company&#39;s</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dis#NYSE">DIS</a>) streaming video-on-demand service Disney+ starting July 3, the show&#39;s creator Lin-Manuel Miranda confirmed on Tuesday.</p> <blockquote class="twitter-tweet"><p>It&#39;s only a matter of time...</p> <p>Our Hamilton film.<br /> THIS July 3rd.<br /> On Disney+.<a href="https://twitter.com/hashtag/Hamilfilm?src=hash&amp;ref_src=twsrc%5Etfw">#Hamilfilm</a> <a href="https://t.co/cXTM949hRr">pic.twitter.com/cXTM949hRr</a></p> <p>&mdash; Lin-Manuel Miranda (@Lin_Manuel) <a href="https://twitter.com/Lin_Manuel/status/1260181905909129216?ref_src=twsrc%5Etfw">May 12, 2020</a></p></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><p>Disney had acquired distribution rights for the broadway production earlier in February at a hefty price of $75 million. The entertainment giant was reported to be considering ...</p><p><a href=https://www.benzinga.com/news/20/05/16018174/hamilton-movie-to-stream-on-disney-in-july alt=&#039;Hamilton&#039; Movie To Stream On Disney+ In July>Full story available on Benzinga.com</a></p> Broadway DIS Hamilton News video streaming Media General DIS US2546871060 News Media General Benzinga Wed, 13 May 2020 05:47:44 +0000 Neer Varshney 16018174 at https://www.benzinga.com Gilead Shares Drop As It Agrees To 'Royalty-Free' Coronavirus Drug Licence With Generic Drugmakers In 127 Countries https://www.benzinga.com/general/biotech/20/05/16018027/gilead-shares-drop-as-it-agrees-to-royalty-free-coronavirus-drug-licence-with-generic-drugmakers- <p><strong>Gilead Sciences, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gild#NASDAQ">GILD</a>) shares dropped on Tuesday as the company <a href="https://www.gilead.com/purpose/advancing-global-health/covid-19/voluntary-licensing-agreements-for-remdesivir">announced</a> it had&nbsp;signed a voluntary licensing agreement with five generic drugmakers to manufacture and supply its drug Remdesivir in 127 countries.</p> <h3>What Happened</h3> <p>The pharmaceutical company said it signed agreements with India-based Cipla Ltd., Hetero Labs Ltd., Jubilant Lifesciences, Pakistan-based Ferozsons Laboratories, and Netherlands-based Myla to manufacture the drug, which has been found useful for novel coronavirus (COVID-19) patients, for distribution in 127 countries.</p> <p>The list of countries posted by Gilead consists of a majority of low ...</p><p><a href=https://www.benzinga.com/general/biotech/20/05/16018027/gilead-shares-drop-as-it-agrees-to-royalty-free-coronavirus-drug-licence-with-generic-drugmakers- alt=Gilead Shares Drop As It Agrees To &#039;Royalty-Free&#039; Coronavirus Drug Licence With Generic Drugmakers In 127 Countries>Full story available on Benzinga.com</a></p> Biotech Covid-19 GILD News Vaccines World Health Organization Health Care Global General GILD US3755581036 News Biotech Health Care Global General Benzinga Wed, 13 May 2020 05:30:55 +0000 Neer Varshney 16018027 at https://www.benzinga.com LeddarTech Announces Volume Production of the Leddar Pixell Cocoon LiDAR with Manufacturing Partner Clarion Malaysia, a member of the Faurecia Clarion Electronics Business Group https://www.benzinga.com/pressreleases/20/05/g16018208/leddartech-announces-volume-production-of-the-leddar-pixell-cocoon-lidar-with-manufacturing-partne <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">QUEBEC CITY, May 13, 2020 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=NRutGmAbDnTH7MkQDy_tHPpvWTAPdx6U2UvIWI_e31E8HvkWA_Tro8SdJQK6BQ2IlSPIv9MsNBx4O8ggKUx1DQ==" rel="nofollow" target="_blank" rel="nofollow">LeddarTech</a>®, an industry leader in LiDAR technology who provides the most versatile and scalable <a href="https://www.globenewswire.com/Tracker?data=w8yVyIulmVkxTBi50qbtBsPzK2KOI0u6dFsHnDpuDDl7nIZiPWXP1SpvReGSc5d-HPBKE3p7IcK5R6F8NQQmSXsHsw5_j7vYColcDAxOYSbBx6rMBEVD_DVrRP1yj5tg98ZkZsSznXVeeFdhmpXrTwUl5zp0Yw2VhaxpumO4UMg=" rel="nofollow" target="_blank" rel="nofollow">auto and mobility LiDAR platform</a>, announces it will begin volume production of the <a href="https://www.globenewswire.com/Tracker?data=NRutGmAbDnTH7MkQDy_tHA-fcR5iJcR97GeGD4LCBhQfk4hcGqJzCWsKKHVcEl7SxznPLfhGaBBFO290hEx3izag9z7xzWf_4wp8ZEzGUa8=" rel="nofollow" target="_blank" rel="nofollow">Leddar<sup>TM</sup> Pixell</a> Cocoon LiDAR Module with their selected partner Clarion Malaysia, a member of Faurecia Clarion Electronics, a business Group of Faurecia.<br /></p> <p align="justify">The Leddar Pixell is an award-winning 3D solid-state flash LiDAR with a field-of-view of 180-degree designed and tested for off-road, shuttles, robotaxis, delivery, commercial and heavy industry vehicles in addition to other robotic and automated applications where solid-state LiDAR is the best 3D sensing option. The Leddar Pixell provides highly reliable detection of pedestrians, cyclists and other obstacles in the vehicle&#039;s vicinity and is ideal for use in perception platforms that are meant to ensure the safety and protection of vulnerable road users (VRU). The Leddar Pixell is an optimal detection cocoon solution for autonomous vehicle deployment and has already been adopted by leading autonomous vehicle providers in North America, Asia and Europe.</p> <p align="justify">Leddar Pixell integrates LeddarTech&#039;s patented technologies embedded in the state-of-the-art <a href="https://www.globenewswire.com/Tracker?data=9nef5bmYpDr9-g79EguxNimj5eAJqdBqejVJLoKnclLYgVZ9MbMJrV3ID7kpVZLSWy_hs6mndvusMHr__Y7fOBfk9KZJElC7JxcY85zW9ci0966OUObIOiZivUO-D8bH" rel="nofollow" target="_blank" rel="nofollow">LCA2 LeddarEngine<sup>TM</sup></a>. The LCA2 uses LeddarTech&#039;s LeddarSP™ (signal processing software) to produce raw LiDAR data such as distance, position, and intensity of echoes. LCA2 is suitable for a wide range of applications and ...</p><p><a href=https://www.benzinga.com/pressreleases/20/05/g16018208/leddartech-announces-volume-production-of-the-leddar-pixell-cocoon-lidar-with-manufacturing-partne alt=LeddarTech Announces Volume Production of the Leddar Pixell Cocoon LiDAR with Manufacturing Partner Clarion Malaysia, a member of the Faurecia Clarion Electronics Business Group>Full story available on Benzinga.com</a></p> Partnerships Press Releases General Wed, 13 May 2020 04:10:10 +0000 Globe Newswire 16018208 at https://www.benzinga.com RAJANT AND HITACHI ANNOUNCE THE SUCCESSFUL DEPLOYMENT OF AUTONOMOUS HAULING SYSTEM IN AUSTRALIAN COAL MINE https://www.benzinga.com/pressreleases/20/05/g16016183/rajant-and-hitachi-announce-the-successful-deployment-of-autonomous-hauling-system-in-australian-c <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>Malvern, Pennsylvania (USA), May 12, 2020 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=jfJr-rLa6nPxEiyUIs1R_Vc-xzd65e93iI_AsOme_9roaCoUpHvtgajcMdEqbpkF0k4-TiPCWQOZ5AZSGrTIFcRiLthrp8n5FOAfYvlyyl_4C6KbmQqgzAiMwV1vbv_UDO75YXrGKgcV5haJHBm_tJOUBdNizm-P3aKU3dVUrhc=" rel="nofollow" target="_blank" rel="nofollow">Rajant Corporation</a>, the provider of Kinetic Mesh® wireless networks, and Hitachi Construction Machinery Australia are improving operational safety and productivity through the use of autonomous haulage systems in an Australian coal mine. Hitachi selected Rajant Kinetic Mesh because it is the only industrial wireless network enabling vehicle-to-vehicle (V2V) communication, which allows autonomous vehicles to talk directly to each other, providing enhanced coverage and reliability.</p> <p>"Rajant is a Hitachi central wireless network partner for the mining industry when it comes to automation," according to Hitachi&#039;s Greg Smith: General Manager AHS Business Unit, Australia. "Deployed in 200 of the largest mines globally, Rajant has the network Hitachi relies on for our autonomous haulage systems, significantly reducing human exposure to safety hazards in mining&#039;s hostile environments."</p> <p>"We have more than a dozen autonomous vehicle partners today, and that list is growing continuously," shares Robert Schena, CEO of Rajant. "In our Australian coal mine deployment with Hitachi, there are currently six autonomous haul trucks ...</p><p><a href=https://www.benzinga.com/pressreleases/20/05/g16016183/rajant-and-hitachi-announce-the-successful-deployment-of-autonomous-hauling-system-in-australian-c alt=RAJANT AND HITACHI ANNOUNCE THE SUCCESSFUL DEPLOYMENT OF AUTONOMOUS HAULING SYSTEM IN AUSTRALIAN COAL MINE>Full story available on Benzinga.com</a></p> Press Releases General Tue, 12 May 2020 21:00:10 +0000 Globe Newswire 16016183 at https://www.benzinga.com E-Prescribing Market To Reach USD 4.22 Billion By 2027 | Reports and Data https://www.benzinga.com/pressreleases/20/05/g16016180/e-prescribing-market-to-reach-usd-4-22-billion-by-2027-reports-and-data <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">New York, May 12, 2020 (GLOBE NEWSWIRE) -- The global <a href="https://www.globenewswire.com/Tracker?data=0RdDaXnIv_dBjBwMBUgpThXnO_STo-cQ_GKTRBiL3sY_HDrsSHH2Mxk04mpZXXtbzcD9cW7Wb6LkMmx-VwQ2FK0AlJckdFLd0OOgbp7d8HC4ZAK5d6yoL0ZXZ6BblvFos2PmA1-sWlIGVEXj0CJfHg==" rel="nofollow" target="_blank" rel="nofollow"><strong>E-Prescribing market</strong></a> is forecast to reach USD 4.22 Billion by 2027, according to a new report by Reports and Data. E-Prescription is gaining traction with the growing adoption of the latest technology in the healthcare sector. It offers an extensive range of applications and provides a comprehensive form of medical data, ensures security checks, and complete privacy of the patient information. </p> <p align="justify">Increasing support from the government is propelling the demand for the market product. The need to reduce medication errors is a major driving factor. However, e-prescribing systems are facing limitations due to the high initial cost and high risk associated with the security and privacy of patient&#39;s data. Developing nations are expected to encounter roadblocks, which includes low availability of high-speed internet connection, and inadequate IT expertise. The fund needed to be allocated to this market is also quite low in emerging nations.</p> <p align="justify">The growing investment in health startups has gained momentum, which has further augmented the demand for the market. The newcomers are coming up with new ways of making these apps more user friendly and are trying to tap into more opportunistic areas of growth. A total of USD 7.5 billion was invested into various start-ups, attempting to digitalize the healthcare system of the U.S. The number was still lower than that invested in 2018, USD 8.1 billion. The U.K.&#39;s Babylon Health was the biggest recipient of investment in 2019, with over USD 500 Million of private investment received, and followed by Ginkgo Bioworks, a bioengineering firm that designs microbes, which received ...</p><p><a href=https://www.benzinga.com/pressreleases/20/05/g16016180/e-prescribing-market-to-reach-usd-4-22-billion-by-2027-reports-and-data alt=E-Prescribing Market To Reach USD 4.22 Billion By 2027 | Reports and Data>Full story available on Benzinga.com</a></p> Health Care Analyst Ratings Press Releases General Tue, 12 May 2020 21:00:10 +0000 Globe Newswire 16016180 at https://www.benzinga.com House Dems Propose Allowing Banks To Service Cannabis Companies As Part Of Coronavirus Bill https://www.benzinga.com/markets/cannabis/20/05/16014806/house-dems-propose-allowing-banks-to-service-cannabis-companies-as-part-of-coronavirus-bill <p>The $3-trillion coronavirus relief bill proposed by House Democrats Tuesday has provisions that should make pot professionals happy.</p> <p>The <a href="http://docs.house.gov/billsthisweek/20200511/BILLS-116hr6800ih.pdf">financial stimulus&nbsp;package</a>, which&nbsp;is meant to offset small business losses on the heels of the COVID-19 pandemic, includes a safe harbor provision for banks.</p> <p>In other words, financial lenders, advisors and institutions would be allowed to provide services to cannabis companies in states where the drug is legal.</p> <p>Today, banks&nbsp;are not allowed to serve the cash-based industry due to federal drug laws,&nbsp;even though cannabis is medically legal in 33 states plus ...</p><p><a href=https://www.benzinga.com/markets/cannabis/20/05/16014806/house-dems-propose-allowing-banks-to-service-cannabis-companies-as-part-of-coronavirus-bill alt=House Dems Propose Allowing Banks To Service Cannabis Companies As Part Of Coronavirus Bill>Full story available on Benzinga.com</a></p> Cannabis cannabis industry Cannabis Laws Coronavirus Covid-19 Government marijuana reform Mitch McConnell Regulations Politics Markets Media General Government Cannabis Regulations Politics Markets Media General Benzinga Tue, 12 May 2020 20:59:54 +0000 Anthony Noto 16014806 at https://www.benzinga.com Uber, GrubHub Analysts Dish Opinions On Reported M&A Talks: 'Not Surprising' https://www.benzinga.com/analyst-ratings/analyst-color/20/05/16014046/uber-grubhub-analysts-dish-opinions-on-reported-m-a-talks-not-surprising <p>If <a href="https://www.benzinga.com/m-a/20/05/16012531/uber-looking-to-eat-up-grubhub-reports">media reports</a> are accurate that <strong>Uber Technologies Inc</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uber#NYSE">UBER</a>) is in talks to acquire rival food delivery platform <strong>GrubHub Inc</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/grub#NYSE">GRUB</a>), it would be both an offensive and defensive move, according to Wedbusgh.</p> <h3>The Uber Analysts</h3> <p>Wedbush analyst <a href="https://www.tipranks.com/analysts/ygal-arounian">Ygal Arounian</a> maintains an Outperform rating on Uber&nbsp;with an unchanged $38 price target.</p> <p>Needham analyst <a href="https://www.tipranks.com/analysts/brad-erickson">Brad Erickson</a> maintains a Buy rating on Uber&#39;s stock with a $42 price target and a Hold rating on GrubHub&#39;s stock.</p> <p>D.A. Davidson analyst <a href="https://www.tipranks.com/analysts/tom-forte">Tom Forte</a> maintains an Underperform rating on GrubHub&nbsp;stock with an unchanged $31 price target.</p> <p>KeyBanc Capital Markets analyst Edward Yruma upgraded GrubHub from Underweight to Sector Weight.</p> <h3>The Wedbush Thesis</h3> <p>Uber&#39;s potentially &quot;aggressive move&quot; to acquire a rival comes at a time when the COVID-19 pandemic forces consumers to place more restaurant orders compared to ride-sharing requests, Arounian said&nbsp;in a note.</p> <p>Despite a large increase in food order&nbsp;requests, profit for the group as a whole remains a &quot;meaningful headwind,&quot; the analyst said.&nbsp;</p> <p>If an acquisition is confirmed, Uber would control 55% of the entire market in third-party food delivery, which would give it a &quot;clear leader&quot; status, he said.</p> <p>This would mark the first time since the end of 2017 that one entity controlled more than half of ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/20/05/16014046/uber-grubhub-analysts-dish-opinions-on-reported-m-a-talks-not-surprising alt=Uber, GrubHub Analysts Dish Opinions On Reported M&amp;A Talks: &#039;Not Surprising&#039;>Full story available on Benzinga.com</a></p> Analyst Color Brad Erickson DA Davidson food Food Delivery GRUB M&A Needham Restaurant Delivery Tom Forte UBER Wedbush Ygal Arounian Upgrades Price Target Reiteration Restaurants Analyst Ratings General GRUB UBER M&A Analyst Color Upgrades Price Target Reiteration Restaurants Analyst Ratings General Benzinga Tue, 12 May 2020 20:34:57 +0000 Jayson Derrick 16014046 at https://www.benzinga.com Gevo Reports First Quarter 2020 Financial Results https://www.benzinga.com/pressreleases/20/05/g16014974/gevo-reports-first-quarter-2020-financial-results <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="left">ENGLEWOOD, Colo., May 12, 2020 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ" rel="nofollow">GEVO</a>) today announced financial results for the first quarter of 2020 and recent corporate highlights.<br /></p> <p><strong>Recent Corporate Highlights</strong></p> <ul> <li>In May 2020, the two wind turbines that will supply up to 5.0 MW of fully renewable electricity to Gevo&#039;s production facility located in Luverne, MN (the "Luverne Facility") were placed into service.  This new renewable source of electricity will enable Gevo to produce its advanced renewable fuels, including hydrocarbons, with a lower-carbon intensity in the future when Gevo resumes production operations at the Luverne Facility.<br /><br /></li> <li>In April 2020, Gevo announced the engagement of Citigroup Global Markets, Inc. to assist Gevo in executing its strategy to finance production of its products using off-balance sheet, project financing structures.<br /><br /></li> <li>In March, due to the impact that the COVID-19 virus had on the economy and Gevo&#039;s industry, Gevo suspended production operations at its Luverne Facility for the foreseeable future.<br /><br /></li> <li>Gevo continues to produce renewable isooctane (gasoline) and jet fuel in Silsbee, TX.</li> </ul> <p><strong>2020 First Quarter Financial Highlights</strong></p> <ul type="disc"> <li>Ended the quarter with cash and cash equivalents of $9.3 million compared to $16.3 as of the end Q4 2019</li> <li>Revenue of $3.8 million for the quarter compared to $6.4 million in Q1 2019</li> <li>Hydrocarbon revenue decreased to $0.1 million for the quarter compared to $0.7 million in Q1 2019</li> <li>Loss from operations of ($8.0) million for the quarter compared to ($5.6) million in Q1 2019</li> <li>Non-GAAP cash EBITDA loss<sup>1</sup> of ($6.2) million for the quarter compared to ($3.8) million in Q1 2019</li> <li>Net loss per share of ($0.64) for the quarter compared to ($0.60) in Q1 2019</li> <li>Non-GAAP adjusted net loss per share<sup>2</sup> of ($0.59) for the quarter compared to ($0.63) in Q1 2019</li> </ul> <p>Commenting on the first quarter of 2020 and recent corporate events, Dr. Patrick R. Gruber, Gevo&#039;s Chief Executive Officer, said "We are focused on building our business for the long run. We continue to make and sell renewable premium gasoline and jet fuel. We&#039;ve cut expenses, cut the burn. We are pleased to be working with Citigroup on our project financings. We are moving forward, and look forward to completing them. Building these projects off balance sheet, where we take the role of developer, licensor and operator, seems to make sense and is expected, once running, to provide attractive cash flows to Gevo and to project investors. Through the pandemic, we&#039;ve seen green value hold, which is good for our business. We&#039;ve seen interest increase in our fuels not just because they lower greenhouse gas emissions, but because they can help to lower particulate and sulfur pollution too. The air is clearing. That is all about the lack of smog from gasoline. Our technology delivers renewable isooctane for gasoline, not just jet fuel."</p> <p><strong>First Quarter 2020 Financial Results</strong></p> <p>Revenue for the three months ended March 31, 2020 was $3.8 million compared with $6.4 million in the same period in 2019.</p> <p>During the three months ended March 31, 2020, hydrocarbon revenue was $0.1 million compared with $0.7 million in the same period in 2019. Hydrocarbon sales decreased because of lower production volumes at the South Hampton Resources, Inc. facility in Silsbee, Texas. Gevo&#039;s hydrocarbon revenue is comprised of sales of alcohol-to-jet fuel and isooctane.</p> <p>During the first quarter of 2020, revenue derived at the Luverne Facility related to ethanol sales and related products was $3.7 million, a decrease of approximately $2.0 million from the same period in 2019. As a result of an unfavorable commodity environment during the three months ended March 31, 2020 compared with the same period ended March 31, 2019, we reduced our production of ethanol and distiller grains, which resulted in lower sales for the period.</p> <p>Cost of goods sold was $8.1 million for the three months ended March 31, 2020, compared with $9.0 million in the same period in 2019, primarily as a result of decreased production of ethanol during the 2019 quarter. Production was decreased due to an unfavorable commodity environment, largely the result of greater corn costs as compared to national markets than the region has historically experienced. Cost of goods sold included approximately $6.5 million associated with the production of ethanol, isobutanol and related products and approximately $1.6 million in depreciation expense for the three months ended March 31, 2020.</p> <p>Gross loss was $4.3 million for the three months ended March 31, 2020, versus a $2.6 million gross loss in the same period in 2019.</p> <p>Research and development expense decreased by $0.4 million during the three months ended March 31, 2020 compared with the same period in 2019, due primarily to a decrease in personnel and consultant expenses.</p> <p>Selling, general and administrative expense increased by $0.7 million during the three months ended March 31, 2020, compared with the same period in 2019, due primarily to an increase in personnel and consulting expenses, partially offset by a decrease in professional fees.</p> <p>We incurred $0.3 million of restructuring expenses related to the termination of 30 employees in March 2020.</p> <p>Loss from operations in the three months ended March 31, 2020 was $8.0 million, compared with a $5.6 million loss from operations in the same period in 2019.</p> <p>Non-GAAP cash EBITDA loss<sup>3</sup> in the three months ended March 31, 2020 was $6.2 million, compared with a $3.8 million non-GAAP cash EBITDA loss in the same period in 2019.</p> <p>Interest expense in the three months ended March 31, 2020 was $0.5 million, a decrease of $0.2 million as compared to the same period in 2019, primarily due to a decline in deferred financing costs and original issue discounts compared to the same period last year.</p> <p align="justify">Gevo incurred $0.7 million of legal and professional fees related to the refinancing of our 2020 Notes Payable during the first quarter of 2020.</p> <p>In the three months ended March 31, 2020, Gevo recognized net non-cash loss totaling $0.1 million due to changes in the fair value of certain of our financial instruments, such as warrants and embedded derivatives.</p> <p>Gevo incurred a net loss for the three months ended March 31, 2020 of $9.3 million, compared with a net loss of $6.1 million during the same period in 2019. Non-GAAP adjusted net loss<sup>4</sup> for the three months ended March 31, 2020 was $8.5 million, compared with a non-GAAP adjusted net loss of $6.4 million during the same period in 2019.</p> <p>Cash at March 31, 2020 was $9.3 million, and the total principal face value of outstanding debt was $14.4 million.</p> <p><strong>Webcast and Conference Call Information</strong></p> <p>Hosting today&#039;s conference call at 4:30 p.m. EDT (2:30 p.m. MDT) will be Dr. Patrick R. Gruber, Chief Executive Officer, Carolyn M. Romero, Vice President—Controller, and Geoffrey T. Williams, Jr., General Counsel. They will review Gevo&#039;s financial results and provide an update on recent corporate highlights.</p> <p>To participate in the conference call, please dial 1 (833) 729-4776 (inside the U.S.) or 1 (830) 213-7701 (outside the U.S.) and reference the access code 9973468# or through the event weblink <a href="https://www.globenewswire.com/Tracker?data=ECkL1pO3iu2KgLGOsjXsoGZ87Bxfp_8xfK_wq0OcFQzE3n35lUqEQDmkGZ6sh5bfxIGS1Dqf2SeeoXoqwIVZWvagvKdLJTC_5UGr_-vO9_Ro0xmoxzHRBOcV514SYwHRs3yKLOFST6nM_IyXy51Baw==" rel="nofollow" target="_blank" rel="nofollow"><u>https://edge.media-server.com/mmc/p/u2xy5aup</u></a>.</p> <p>A replay of the call and webcast will be available two hours after the conference call ends on May 12, 2020. To access the replay, please dial 1 (855) 859-2056 (inside the US) or 1 (404) 537-3406 (outside the US) and reference the access code 9973468#. The archived webcast will be available in the Investor Relations section of Gevo&#039;s website at <a href="https://www.globenewswire.com/Tracker?data=oeGPrQX28Ay0tQIWXwt9dauw89B6hqQgj8cMDfaLgQAhsngLfLaJ6oKMEOa4OCqcd9MeEva4sV03SCytKDpUWA==" rel="nofollow" target="_blank" rel="nofollow"><u>www.gevo.com</u></a>.</p> <p><strong>About Gevo</strong></p> <p>Gevo is a growth-oriented renewable fuels company that is commercializing the next generation of renewable low-carbon liquid transportation fuels with the potential to achieve "net zero" greenhouse gas ("GHG") footprint and address global needs of reducing GHG emissions with sustainable alternatives to petroleum fuels. As next generation renewable fuels, Gevo&#039;s hydrocarbon transportation fuels have the advantage of being "drop-in" substitutes for conventional fuels that are derived from crude oil, working seamlessly and without modification in existing fossil-fuel based engines, supply chains and storage infrastructure. In addition to the potential of net zero carbon emissions across the whole of the fuel life-cycle, Gevo&#039;s renewable fuels eliminate other pollutants associated with the burning of traditional fossil fuels such as particulates and sulfur, while delivering superior performance. Gevo believes that the world is substantially under-supplied with low-carbon, drop-in renewable fuels that can be immediately used in existing transportation engines and infrastructure, and Gevo is uniquely positioned to grow in serving that demand.</p> <p>Learn more at <a href="https://www.globenewswire.com/Tracker?data=oeGPrQX28Ay0tQIWXwt9dVhpuEiICBgjY3YtGCi9m8nwH6s_vmjX9k8bAGebdR6TuAoC1wruZV1XKnuo6fhm9w==" rel="nofollow" target="_blank" rel="nofollow"><u>www.gevo.com</u></a>.</p> <p><strong>Forward-Looking Statements</strong></p> <p>Certain statements in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, including, without limitation, Gevo&#039;s wind projects, Gevo&#039;s ability to successfully finance its operations and growth projects, Gevo&#039;s ability to achieve cash flow from its planned projects, the ability of Gevo&#039;s products to contribute to lower greenhouse gas emissions, particulate and sulfur pollution and other statements that are not purely statements of historical fact. These forward-looking statements are made based on the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2019 and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.</p> <p><strong>Non-GAAP Financial Information</strong></p> <p>This press release contains financial measures that do not comply with U.S. generally accepted accounting principles (GAAP), including non-GAAP cash EBITDA loss, non-GAAP adjusted net loss and non-GAAP adjusted net loss per share. Non-GAAP cash EBITDA excludes depreciation and non-cash stock-based compensation. Non-GAAP adjusted net loss and adjusted net loss per share excludes non-cash gains and/or losses recognized in the quarter due to the changes in the fair value of certain of Gevo&#039;s financial instruments, such as warrants, convertible debt and embedded derivatives<em>.</em> Management believes these measures are useful to supplement its GAAP financial statements with this non-GAAP information because management uses such information internally for its operating, budgeting and financial planning purposes. These non-GAAP financial measures also facilitate management&#039;s internal comparisons to Gevo&#039;s historical performance as well as comparisons to the operating results of other companies. In addition, Gevo believes these non-GAAP financial measures are useful to investors because they allow for greater transparency into the indicators used by management as a basis for its financial and operational decision making. Non-GAAP information is not prepared under a comprehensive set of accounting rules and therefore, should only be read in conjunction with financial information reported under U.S. GAAP when understanding Gevo&#039;s operating performance. A reconciliation between GAAP and non-GAAP financial information is provided in the financial statement tables below.</p> <p>______________________________</p> <p><sup>1</sup> <em>Cash EBITDA loss is a non-GAAP measure calculated by adding back depreciation and non-cash stock compensation to GAAP loss from operations. A reconciliation of cash EBITDA loss to GAAP loss from operations is provided in the financial statement tables following this release.<br /></em><sup>2</sup> <em>Adjusted net loss per share is a non-GAAP measure calculated by adding back non-cash gains and/or losses recognized in the quarter due to the changes in the fair value of certain of our financial instruments, such as warrants, convertible debt and embedded derivatives, to GAAP net loss per share. A reconciliation of adjusted net loss per share to GAAP net loss per share is provided in the financial statement tables following this release.<br /></em><sup>3</sup> <em>Cash EBITDA loss is a non-GAAP measure calculated by adding back depreciation and non-cash stock compensation to GAAP loss from operations. A reconciliation of cash EBITDA loss to GAAP loss from operations is provided in the financial statement tables following this release.<br /></em><sup>4</sup> <em>Adjusted net loss is a non-GAAP measure calculated by adding back non-cash gains and/or losses recognized in the quarter due to the changes in the fair value of certain of our financial instruments, such as warrants, convertible debt and embedded derivatives, to GAAP net loss. A reconciliation of adjusted net loss to GAAP net loss is provided in the financial statement tables following this release.</em></p> <p><strong>Gevo, Inc.</strong><br /><strong>Condensed Consolidated Balance Sheets Information</strong><br /><strong>(Unaudited, in thousands, except share and per share amounts)</strong></p> <table style="border-collapse: collapse; margin-left:0px; width:100%; border-collapse:collapse ;"> <tr> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="3" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; "><strong>March 31, 2020</strong></td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "><strong> </strong></td> <td colspan="3" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; "><strong>December 31, 2019</strong></td> </tr> <tr> <td style="vertical-align: bottom ; "><strong>Assets</strong></td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Current assets:</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="max-width:77%; width:77%; min-width:77%;;vertical-align: bottom ; ">Cash and cash equivalents</td> <td style="max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; ">$</td> <td style="max-width:9%; width:9%; min-width:9%;;padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">9,289</td> <td style="max-width:1%; width:1%; min-width:1%;;padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; ">$</td> <td style="max-width:9%; width:9%; min-width:9%;;padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">16,302</td> <td style="max-width:1%; width:1%; min-width:1%;;padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Accounts receivable</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">152</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">1,135</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Inventories</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">2,680</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">3,201</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Prepaid expenses and other current assets</td> <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">3,838</td> <td style="border-bottom: solid black 1pt ; padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">3,590</td> <td style="border-bottom: solid black 1pt ; padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Total current assets</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">15,959</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">24,228</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Property, plant and equipment, net</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">65,855</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">66,696</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Investment in Juhl</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">1,500</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">1,500</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Deposits and other assets</td> <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">848</td> <td style="border-bottom: solid black 1pt ; padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">935</td> <td style="border-bottom: solid black 1pt ; padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; "> </td> <td style="vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Total assets</td> <td style="border-bottom: double 15px 3pt ; vertical-align: bottom ; ">$</td> <td style="border-bottom: double 15px 3pt ; padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">84,162</td> <td style="border-bottom: double 15px 3pt ; padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-bottom: double 15px 3pt ; vertical-align: bottom ; ">$</td> <td style="border-bottom: double 15px 3pt ; padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">93,359</td> <td style="border-bottom: double 15px 3pt ; padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; "><strong>Liabilities</strong></td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Current liabilities:</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Accounts payable and accrued liabilities</td> <td style="vertical-align: bottom ; ">$</td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">4,477</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="vertical-align: bottom ; ">$</td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">5,678</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">2020/21 Notes (current), net</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">14,050</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; ">―</td> <td style="vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">2020 Notes (current), net</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; ">―</td> <td style="vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">13,900</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">2020/21 Notes embedded derivative liability</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">100</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; ">―</td> <td style="vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Loans payable – other (current)</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">375</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">516</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Total current liabilities</td> <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-top: solid black 1pt ; padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">19,002</td> <td style="border-top: solid black 1pt ; padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-top: solid black 1pt ; padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">20,094</td> <td style="border-top: solid black 1pt ; padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Loans payable – other (long-term)</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">232</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">233</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Other long-term liabilities</td> <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">435</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">528</td> <td style="padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Total liabilities</td> <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">19,669</td> <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ; vertical-align: middle; vertical-align: bottom ; ">20,855</td> <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; padding-left: 0 ; text-align: left ; vertical-align: middle; vertical-align: bottom ; "> </td> </tr> <tr> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; ">Commitments and Contingencies</td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="vertical-align: bottom ; "> </td> </tr> <tr> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; "> </td> <td colspan="2" style="vertical-align: bottom ; "> </td> </tr> <tr> <td style="vertical-align: bottom ; "><strong>Stockholders&#39; Equity</strong></td> <td style="text-align: right ; vertical-align: middle; vertical-align: bottom ; ...</tr></table><p><a href=https://www.benzinga.com/pressreleases/20/05/g16014974/gevo-reports-first-quarter-2020-financial-results alt=Gevo Reports First Quarter 2020 Financial Results>Full story available on Benzinga.com</a></p> Biotech Earnings GEVO Press Releases General Tue, 12 May 2020 20:05:10 +0000 Globe Newswire 16014974 at https://www.benzinga.com GGP 150 VIRTUAL CONCERT SERIES ANNOUNCES MAY LINE-UP; A special Summer Solstice performance and Comedy Day Classics in the Park https://www.benzinga.com/pressreleases/20/05/g16014660/ggp-150-virtual-concert-series-announces-may-line-up-a-special-summer-solstice-performance-and-com <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>San Francisco, May 12, 2020 (GLOBE NEWSWIRE) -- Golden Gate Park&#039;s 150<sup>th</sup> anniversary virtual concert series will continue to bring classic performances from the park to visitors during the month of May.  Today, organizers announced two specially-produced music and comedy concerts on May 16 and May 30, respectively, that will celebrate the park through an exciting virtual experience.  </p> <p>The virtual concerts can be viewed at <a href="https://www.globenewswire.com/Tracker?data=1hUaZvkajm-xKKeFSq5d5ruylLKZDaajGiNf-YxmqV9QjlurY7zuuiSjxy7WF4z7Qk8I4fJ1bnUj1VDBwGSfWKnG7farkEo2Yzki3OBwHaM=" rel="nofollow" target="_blank" rel="nofollow">GoldenGatePark150.com</a>.</p> <p>On <u>Saturday, May 16 at 5 p.m. PST</u>, viewers will enjoy a livestream special production of 2019&#039;s Surrealistic Summer Solstice Jam, celebrating the music of 1969.  Surrealistic Summer Solstice Jam 3 was produced by Dawn Holliday with the musical direction of Dan "Lebo" Lebowitz.  </p> <p>The two-hour special virtual concert will feature Bay Area music legends that include: Norman Greenbaum, Country Joe McDonald, New Chambers Brothers, It&#039;s a Beautiful Day, Ace of Cups, as well as founding members of iconic Bay Area bands like Jefferson Starship, Sly &amp; The Family Stone, Big Brother &amp; The Holding Company, Santana, Jerry Garcia Band,  New Riders of the Purple Sage, Rat Dog, and The Sons of Champlin.   These local luminaries are joined by musicians from the newer generation of San Francisco bands including ALO, Box Set, Moonalice, Con Brio, Brothers Comatose, The California Honeydrops, Strangefolk, Midnight North, T Sisters, Katdelic, The Brothers Comatose, and Tarnation.</p> <p>"Last year&#039;s solstice concert was a legendary night, which saw the melding of multiple generations of San Francisco musicians, spanning rock and roll&#039;s most iconic genre defining ...</p><p><a href=https://www.benzinga.com/pressreleases/20/05/g16014660/ggp-150-virtual-concert-series-announces-may-line-up-a-special-summer-solstice-performance-and-com alt=GGP 150 VIRTUAL CONCERT SERIES ANNOUNCES MAY LINE-UP; A special Summer Solstice performance and Comedy Day Classics in the Park>Full story available on Benzinga.com</a></p> lifestyle News Retail Sales Press Releases General Tue, 12 May 2020 19:39:33 +0000 Globe Newswire 16014660 at https://www.benzinga.com Oga's Japanese Cuisine Launches ImmunOGA, Immune Boosting Sushi Combos and Joins the Fight Against COVID-19 https://www.benzinga.com/pressreleases/20/05/g16014602/ogas-japanese-cuisine-launches-immunoga-immune-boosting-sushi-combos-and-joins-the-fight-against-c <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>BOSTON, May 12, 2020 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=CUQPIkMCSo0lyPw15KgH9R5xqqiO9BAimJ7nSweG1Avi2NI_OTa1E9408IVQxjkP3WQDHd3y546-o9LKCKaylVhZLGmMh4lVZU3vxenUskA=" rel="nofollow" target="_blank" rel="nofollow"><u>Oga&#039;s Japanese Cuisine</u></a>, a favorite local eatery located at 915 Worcester Street in Natick MA is featuring ImmunOGA, a <a href="https://www.globenewswire.com/Tracker?data=TqFOUnq8abQM3FTIKrXgpV0j39PjHq4-ulat1IsDm5X8RazarkNvqwKqAfO3q1f-WwQF6DA3aeik5eY6COI35HX2c1P_i1Mahase391mgE5pwkj7nOMxm3wCw58gmp0Xns2d2d_-c5DCSo-CwTZu4g==" rel="nofollow" target="_blank" rel="nofollow"><u>sushi combination box</u></a> for boosting Immunity. Among other offerings from their <a href="https://www.globenewswire.com/Tracker?data=9P6nupeb7weZ7as898Sm6394ivaJH9_IEVsbgsHCJ62zgclTwri6wCINTN8XxqnmSz9we8ZQWKBM2wIbWdQ2Aa6jgFB2LtWl4DHq-c23Qmg=" rel="nofollow" target="_blank" rel="nofollow"><u>menu</u></a>, this combination highlights sushi items that are not only very popular, but have ultimate immune boosting benefits to fight against the current COVID-19 pandemic.<br /></p> <p>We all know the health benefits of adding fish to our diets regularly. The AHA recommends including fatty fish and white fish to our diets at least twice weekly for important nutrients like Omega-3 fatty acids. Sushi for Immunity is a powerhouse combo that comprises a spectrum of nutritional elements including lean ...</p><p><a href=https://www.benzinga.com/pressreleases/20/05/g16014602/ogas-japanese-cuisine-launches-immunoga-immune-boosting-sushi-combos-and-joins-the-fight-against-c alt=Oga&#039;s Japanese Cuisine Launches ImmunOGA, Immune Boosting Sushi Combos and Joins the Fight Against COVID-19>Full story available on Benzinga.com</a></p> Restaurants Press Releases General Tue, 12 May 2020 19:31:43 +0000 Globe Newswire 16014602 at https://www.benzinga.com Meritage Reports First Quarter 2020 Results https://www.benzinga.com/pressreleases/20/05/g16014591/meritage-reports-first-quarter-2020-results <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">GRAND RAPIDS, Mich., May 12, 2020 (GLOBE NEWSWIRE) -- Meritage Hospitality Group Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MHGU#OTCQX" rel="nofollow">MHGU</a>), one of the nation&#039;s premier restaurant operators, today reported financial results for the first quarter ended March 29, 2020.<br /></p> <p align="justify"><strong>First Quarter Highlights</strong></p> <ul type="disc"> <li style="text-align:justify;"><strong>Sales increased 7.3% to $117.8 million compared to $109.8 million for the same period last year. </strong></li> <li style="text-align:justify;"><strong>Loss from Operations was $0.2 million compared to Income from Operations of $5.4 million for the same period last year. </strong></li> <li style="text-align:justify;"><strong>Net Loss was $3.7 million compared to Net Income of $4.1 million for the same period last year. (The change in earnings includes a negative year over year non-cash GAAP change of $1.0 million resulting from the Company&#039;s interest rate swap agreements, which are measured at fair value based on mark-to-market.)</strong></li> <li style="text-align:justify;"><strong>Consolidated EBITDA (a non-GAAP measure) was $4.5 million compared to $12.5 million for the same period last year. (Last year included a $3.6 million real estate gain)</strong></li> <li style="text-align:justify;"><strong>The Company owned 335 restaurants compared to 318 for the same period last year.</strong></li> </ul> <p align="justify">"The first quarter for the Company&#039;s restaurant business was a tale of two extremes. Early in the quarter, we hired 1,400 additional team members across our Wendy&#039;s restaurant system, preparing for the national breakfast roll-out. We experienced record same store sales growth from breakfast, which continues to perform well in the social distancing environment. The ...</p><p><a href=https://www.benzinga.com/pressreleases/20/05/g16014591/meritage-reports-first-quarter-2020-results alt=Meritage Reports First Quarter 2020 Results>Full story available on Benzinga.com</a></p> Earnings MHGU Restaurants Press Releases General Tue, 12 May 2020 19:30:10 +0000 Globe Newswire 16014591 at https://www.benzinga.com Neocis Announces New FDA 510(k) Clearance for Yomi® to Enhance CT Scanner Compatibility https://www.benzinga.com/pressreleases/20/05/g16014383/neocis-announces-new-fda-510-k-clearance-for-yomi-to-enhance-ct-scanner-compatibility <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">MIAMI, May 12, 2020 (GLOBE NEWSWIRE) -- Neocis, Inc., the leader and innovator in dental implant surgery using advanced robotics, today announced a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new component for use with Yomi. This component reduces the CT scanner field-of-view (FOV) requirements, which broadens the target market for adopting robot-assisted dental surgery.<br /></p> <p align="justify">Yomi, the first and only FDA cleared robot-assisted dental surgery system, provides robot-assisted guidance relative to a pre-operative plan based on a CT scan. Many dental offices have in-office cone beam CT scanners, which provide a true 3D visualization of the patient as compared to a 2D x-ray or projected panoramic scan. The Yomi system is compatible with all DICOM format CT scans, which includes most scanners on the market. CT scanners vary in the field-of-view that they offer. With the latest clearance, Yomi will be ...</p><p><a href=https://www.benzinga.com/pressreleases/20/05/g16014383/neocis-announces-new-fda-510-k-clearance-for-yomi-to-enhance-ct-scanner-compatibility alt=Neocis Announces New FDA 510(k) Clearance for Yomi® to Enhance CT Scanner Compatibility>Full story available on Benzinga.com</a></p> Press Releases General Tue, 12 May 2020 19:00:10 +0000 Globe Newswire 16014383 at https://www.benzinga.com Inovio Analysts Tackle Coronavirus Vaccine Timeline, Funding, Pipeline After Q1 Report https://www.benzinga.com/analyst-ratings/analyst-color/20/05/16012507/inovio-analysts-tackle-coronavirus-vaccine-timeline-funding-pipeline-after-q1-repor <p>Despite <strong>Inovio Pharmaceuticals Inc&#39;s </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ino#NASDAQ">INO</a>)&nbsp;<a href="https://www.benzinga.com/general/biotech/20/05/16005335/inovio-q1-results-miss-estimates-coronavirus-vaccine-program-on-track">first-quarter miss Monday</a>, the sell-side remains largely upbeat on company, which is developing a coronavirus vaccine candidate.&nbsp;</p> <h3>The Inovio Analysts</h3> <p>Stifel analyst <a href="http://https://www.tipranks.com/analysts/stephen-willey">Stephen Wiley</a> maintained a Buy rating and $19 price target for Inovio shares.</p> <p>H.C. Wainwright analyst <a href="http://https://www.tipranks.com/analysts/ram-selvaraju">Raghuram Selvaraju</a> reiterated a Buy rating and $17 price target.&nbsp;</p> <h3>Stifel Sees Viable Pathway For External Funding</h3> <p>The ongoing Phase 1 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/20/04/15875749/a-deep-dive-on-coronavirus-vaccine-plays-moderna-inovio"> INO-4800 development program </a> for the new coronavirus is likely to remain a source of continued volatility in the light of the emerging competitive landscape, Stifel analyst Wiley said in a Monday note.</p> <p>Inovio stated that all healthy volunteers will receive the second dose of INO-4800 by the end of May and preliminary safety and&nbsp;immunogenicity data will be available in late June, the analyst said.</p> <p>The company expects the vaccine to be available under emergency use authorization ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/20/05/16012507/inovio-analysts-tackle-coronavirus-vaccine-timeline-funding-pipeline-after-q1-repor alt=Inovio Analysts Tackle Coronavirus Vaccine Timeline, Funding, Pipeline After Q1 Report>Full story available on Benzinga.com</a></p> Analyst Color Biotech Coronavirus Covid-19 Earnings H.C. Wainwright INO INO-4800 News Raghuram Selvaraju Stephen Wiley Stifel Health Care Price Target Reiteration Analyst Ratings Movers Trading Ideas General INO US45773H1023 News Analyst Color Earnings Biotech Health Care Price Target Reiteration Analyst Ratings Movers Trading Ideas General Benzinga Tue, 12 May 2020 18:49:28 +0000 Shanthi Rexaline 16012507 at https://www.benzinga.com Blue Diamond Resorts Implements New Safety-Assured Vacations Protocols https://www.benzinga.com/pressreleases/20/05/g16014304/blue-diamond-resorts-implements-new-safety-assured-vacations-protocols <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="left">TALLAHASSEE, Fla., May 12, 2020 (GLOBE NEWSWIRE) -- Blue Diamond Resorts prepares to welcome guests back to its resorts with enhanced health, safety and cleanliness programs, brand-wide. The resort management group&#039;s Safety-Assured Vacations protocols will be implemented at each of Blue Diamond&#039;s 47 properties across the Caribbean, Central America and Mexico.<br /></p> <p>Advanced sanitation measures, new physical distancing guidelines, a 360º Clean Approach and an International Safety Assurance Team are in place to prioritize well-being across every area and touchpoint of Blue Diamond Resorts properties. To help protect both guests and staff members, the new and enhanced Safety-Assured Vacations protocols will adhere to the guidelines of the Centers for Disease Control (CDC) and the World Health Organization (WHO), as well as the local and national Ministries of Health.</p> <p>"As the countries which our resorts call home begin to re-open, we want to ensure our guests feel safe and cared for when choosing to stay at a Blue Diamond property," said Jordi Pelfort, President of Hotels and Resorts at Sunwing Travel Group. "By heightening our industry-leading sanitation practices, we will continue to guarantee luxurious, relaxing and Safety-Assured Vacations for all of our valued guests."</p> <p>The Safety-Assured Vacations program includes:</p> <ul type="disc"> <li><strong>Safe Vacation Assurance:</strong> In accordance with international health standards, including the Centers for Disease Control (CDC), World Health Organization (WHO) and local/ national Ministries of Health, a Safety-Assurance Team is in position to ensure the strict adherence of all guidelines and comprehensive implementation of sanitation, physical distancing and cleaning protocols to protect guests and employees alike. </li> <li><strong>360º Clean Approach</strong>: All resort common areas including pools, beaches, restaurants, bars, entertainment facilities, lobbies, elevators, hallways and other shared spaces will be cleaned hourly. All high-touch surfaces, including general transportation units like golf carts and luggage trolleys, will continuously be sanitized throughout the day, plus fitness center equipment and spa facilities will be sanitized after each use. Blue Diamond ...</li></ul><p><a href=https://www.benzinga.com/pressreleases/20/05/g16014304/blue-diamond-resorts-implements-new-safety-assured-vacations-protocols alt=Blue Diamond Resorts Implements New Safety-Assured Vacations Protocols>Full story available on Benzinga.com</a></p> Press Releases General Tue, 12 May 2020 18:47:47 +0000 Globe Newswire 16014304 at https://www.benzinga.com